An interventional study of DIXI Medical Microdeep® Micro- Macro Depth electrodes and Standard electrodes in Epilepsy, sponsored by University Hospital, Toulouse. Recruiting at 12 sites in France. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-10-21.
Sponsored by University Hospital, Toulouse · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 10 studies in Epilepsy by University Hospital, Toulouse — 5 open to participants now, 6 under way, none of them phase 3. Epilepsy · University Hospital, Toulouse.
Among the 10 studies in Epilepsy by University Hospital, Toulouse, this one is the only one that started in 2024, is one of 6 with no phase, and was the 8th registered.
1,850 studies on the registry are indexed under Epilepsy; 418 are open to participants now.
Browse Epilepsy studies →5 of the 10 studies in Epilepsy by University Hospital, Toulouse are open now, in 1 country. Recruiting first, the newest first:
University Hospital, Toulouse · Sites in France
Ages 18+
University Hospital, Toulouse · Sites in France
Ages 3–50
University Hospital, Toulouse · Sites in France
Ages 12–65
University Hospital, Toulouse · Sites in France
Ages 18–65
By country, each count listing its studies:
Of the 284 Epilepsy studies recruiting now, 113 (40%) set no upper age limit and 148 (52%) stop at 75 or younger; 138 take children under 18; 54 take healthy volunteers.
This study: 18 Years to 65 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
10 studies; the count open now beside each. This study's row is marked.
First in 2015; this study’s year is marked. 1 started in 2024.
This study's planned enrollment of 440 is above the median of 50 across 1,240 interventional studies indexed under Epilepsy.
Median enrollment 61 across the 6 interventional studies, 113 across the 4 observational. Of the 2 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
University Hospital, Toulouse is the lead sponsor of 809 studies on the registry; 211 are open to participants now.
1 of the studies in Epilepsy by University Hospital, Toulouse that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT03738072University Hospital, ToulouseIntracerebral Electrical Stimulation and the Optimisation of Presurgical Planning in Drug-refractory Partial Epilepsy | 2026-12 |
Add it to your calendar (.ics) → With an account.
Among the 10 studies in Epilepsy by University Hospital, Toulouse, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The main aim of this study is to evaluate the contribution of fast-ripples (FR) information on the neurosurgery management of patients with drug-refractory epilepsy investigated by Stereo-ElectroEncephaloGraphy (SEEG), as measured by freedom from disabling seizures one-year post-surgery.
220 patients (for whom 4-6 usual clinical macro-electrodes will be replaced by hybrid micro-macro electrodes and for whom fast-ripples will be assessed) distributed over 6 centres and 220 control patients(who will undergo an SEEG with the usual electrodes and for whom fast-ripples will not be assessed) distributed over 6 centres. This is a controlled, non-randomized, parallel plan, prospective, multicentre exploratory study.
This is a controlled, non-randomized, parallel plan, prospective, multicentre exploratory study. The design of the study relies on two groups of patients benefiting from a SEEG, equivalent in size: one with standard and hybrid electrodes for which fast-ripple information will be available for the neurosurgery decision, the other, who will serve as a control group, with standard electrodes only and for which no information regarding fast-ripples will be provided. For all patients undergoing SEEG, the decisions about eligibility to epilepsy surgery and, if eligible, about the best surgical plan, are taken during a multidisciplinary epilepsy meeting (MEM) within the 4 +/- 2 months following the SEEG. In the group of patients with standard and hybrid electrodes, the procedure as extensively tested previously, is to plan the implantation of the standard electrodes as usually done, and once done, to replace from 4 to 6 standard electrodes with hybrid electrodes. In this group, intracerebral ElectroEncephaloGraphy (EEG) data will be acquired for detection of fast-ripples, during one hour of a rest period for 2 days during the first week of SEEG, as well as during one cycle of night sleep when possible. Fast-ripples(number, localization and characteristics) for all these patients will be analysed by an expert group of neuroscientists based in Toulouse blind to the analysis of the Epileptogenic Zone (EZ), irritative and propagation zones and on all micro- and macro contacts, to the participating centre and to the period of recording. The results of the fast-ripple assessment will be provided to the clinicians on time for the MEM. They will incorporate this information along other usual clinical information gathered during the SEEG to reach a conclusion regarding the possibility of a neurosurgery. No analysis of the fast-ripples will be performed in the other group of patients with standard electrodes only. In this group, the conclusion regarding the possibility of a neurosurgery will thus be done during the MEM with the standard clinical information gathered during the SEEG only. Following epilepsy surgery, the typical follow-up performed in routine in all participating centres includes a clinical evaluation one year after surgery, during which Engel class is assessed.
The criteria were revised on the registry on Oct 21, 2026. See what changed
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients for whom 4-6 usual clinical macro-electrodes will be replaced by hybrid micro-macro electrodes and for whom fast-ripples will be assessed
Device: DIXI Medical Microdeep® Micro- Macro Depth electrodes
Patients who will undergo an SEEG with the usual electrodes and for whom fast-ripples will not be assessed.
Device: Standard electrodes
It is a deep intracerebral electrode used in the pre-surgical diagnosis of certain drug-resistant epilepsies. It consists of micro- and macro-contacts and is designed for Stereo-ElectroEncephalography (SEEG) recording via the macro-contacts or micro-contacts and brief stimulation via the macro-contacts.
Standard electrodes used usually during the SEEG
Contribution of fast-ripples information on freedom seizures
Proportion of patients with Engel class I after one-year post-surgery in the group of patients with information of fast-ripples compared to patients without.
Time frame: 12 months after epilepsy surgery
Contribution of fast-ripples information on improvement of epilepsy
Proportion of patients with Engel classes I to III one-year post-surgery of patients with information of fast-ripples compared to patients without.
Time frame: 12 months after epilepsy surgery
Contribution of fast-ripples information on patients addressed to neurosurgery
Proportion of patients operated for their epilepsy in the group of patients with information of fast-ripples compared to patients without.
Time frame: 12 months after epilepsy surgery
Adverse effects related to Stereo-electroencephalography
Quantitative and qualitative description of adverse effects related to the Stereo-electroencephalography (SEEG) in the group of patients with information of fast-ripples compared to patients without.
Time frame: Day 0 (SEEG visit)
Adverse effects of epilepsy surgery
Quantitative and qualitative description of adverse effects related to epilepsy surgery in the group of patients with information of fast-ripples compared to patients without.
Time frame: 6 months after surgical decision
Adverse effects of hybrid electrodes
Quantitative and qualitative description of adverse effects related to the hybrid electrodes.
Time frame: Day 0 (SEEG visit)
Post-operative neurological deficit
Number of patients suffering from disabling post-operative neurological deficit, anxiety or depression in the group of patients with information of fast-ripples versus patients without
Time frame: 12 months after epilepsy surgery
Evolution of quality of life using the score of Quality of life Epilepsy Inventory Epilepsy Inventory
Delta of quality of life using the score of Quality of life Epilepsy Inventory (QOLIE-31) between baseline and 12 months related to epilepsy surgery in the group of patients with information of fast-ripples compared to patients without. QOLIE-31 is a 31-item questionnaire with different proposal scores. The maximal total score is 100 : the higher the score, the better the quality of life
Time frame: 12 months after epilepsy surgery
Level of satisfaction
Mean of level of satisfaction with the outcome of epilepsy surgery assessed using the Evaluation of changes in daily life after epilepsy surgery (EVOCQUE) self-questionnaire, 12 months after surgery, related to epilepsy surgery in the group of patients with information of fast-ripples compared to patients without. EVOCQUE is a self-questionnaire with ten different questions and proposal scores.
Time frame: 12 months after epilepsy surgery
Recording of fast-ripples
Number of fast-ripples recorded on the hybrid electrodes, on the one hand on the micro- contacts and on the other hand on the adjacent macro-contacts of the same hybrid electrode.
Time frame: Day 0 (SEEG visit)
Distribution of the fast-ripples
Number of fast-ripples in the Epileptogenic Zone, Irritative Zone and healthy zone
Time frame: Day 0 (SEEG visit)
Number of fast-ripples recorded according to the period
Number of fast-ripples recorded during one period of sleep, an equivalent period of nap and an equivalent period of sitcom watching.
Time frame: Day 0 (SEEG visit)
Contribution of using an Epileptogenicity Index
Proportion of patients in Engel class I at one year after surgery among those whose epileptogenic zone was evaluated using an Epileptogenicity Index vs those whose epileptogenic zone was not evaluated using an Epileptogenicity Index in the group of patients with FR information and in the group of patients without FR information.
Time frame: 12 months after epilepsy surgery
Impact of RF-TC (Radiofrequency- Thermocoagulation) by SEEG on epilepsy at 4 months
Proportion of seizure-free patients at 4 and 10 months post- SEEG (visits 3 and 4), among patients who underwent SEEG based RF-TC in the group of patients with FR information and in the group of patients without FR information.
Time frame: Visit 3 : 4 months post-SEEG
Impact of RF-TC (Radiofrequency- Thermocoagulation) by SEEG on epilepsy at 10 months
Proportion of seizure-free patients at 10 months post- SEEG (visit 4), among patients who underwent SEEG based RF-TC in the group of patients with FR information and in the group of patients without FR information.
Time frame: Visit 4 : 10 months post-SEEG
Started Jan 2024 (actual). Primary completion is estimated for Apr 2030, 75 months after the start.
Of 339 non-industry interventional studies with no phase under Epilepsy, half reached primary completion within 43 months of starting (the median), counting those still running; a quarter within 19 and three quarters within 77. This study's planned 75 months is above that.
Counting every sponsor, half of 360 studies reached it within 42 months; a quarter within 19 and three quarters within 77.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Toulouse →